<bill session="114" type="h" number="6463" updated="2017-07-20T13:50:03Z">
  <state datetime="2016-12-07">REFERRED</state>
  <status>
    <introduced datetime="2016-12-07"/>
  </status>
  <introduced datetime="2016-12-07"/>
  <titles>
    <title type="short" as="introduced">Patient Safety and Toxicology Modernization Act of 2016</title>
    <title type="official" as="introduced">To direct the Secretary of Health and Human Services to issue guidance with respect to three-dimensional human tissue models, and for other purposes.</title>
    <title type="display">Patient Safety and Toxicology Modernization Act of 2016</title>
  </titles>
  <sponsor id="412563"/>
  <cosponsors>
    <cosponsor id="412445" joined="2016-12-07"/>
  </cosponsors>
  <actions>
    <action datetime="2016-12-07">
      <text>Introduced in House</text>
    </action>
    <action datetime="2016-12-07" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2016-12-07T05:00:00Z" status="Introduced in House">Patient Safety and Toxicology Modernization Act of 2016

This bill requires the Food and Drug Administration to issue and periodically update guidance on: (1) novel tools for testing the toxicology and efficacy of medications, and (2) three-dimensional human tissue models.</summary>
  <committee-reports/>
</bill>
